Skip to content

Peptide fragment analysis for prohormone conversion (specifically proinsulin or related peptide fragments)

Published: August 9, 2026Updated: August 16, 2026

This test measures small peptide fragments produced during the breakdown of proinsulin, a precursor to insulin. It helps assess pancreatic function and diabetes management.

Quick summary

["This test helps track how well your body processes insulin and may aid in diabetes care."]

Medically reviewed by WellAlly Editorial TeamLast reviewed August 16, 2026Editorial policy

Key facts at a glance

LOINC
58497-9
Short code
C peptide sp11 p chal SerPl-mCnc
Synonyms
C peptide sp11 p chal SerPl-mCnc
Category
coagulation
Sample
serum
Container
Red-top tube (SST)
Units
N/A
Ref low
0.8
Ref high
1.2
Critical range
— – 5 N/A
Fasting
false
Population
adult
Sex
all
Age range
18–65 years
CPT
85610
SNOMED
396252006
Specimen volume
5 mL
Stability
Room temperature: 4h, Refrigerated: 24h, Frozen: 7d
Hemolysis max
500
Lipemia max
1000
Icterus max
500
TAT
4–24 hours
Order
routine

Why This Test Is Done

Doctors may order this test to evaluate pancreatic health, especially in people with diabetes or suspected insulin-related disorders. It can also help monitor treatment progress for conditions affecting insulin production.

What to Expect Before the Test

No special preparation is typically needed. Blood is drawn from a vein, usually in your arm. You may feel slight discomfort, but it usually lasts only a few minutes.

How the Results Are Interpreted

Results are compared to general reference ranges for peptide fragments. Elevated levels may indicate issues with insulin processing or diabetes complications, while abnormal patterns could signal other metabolic concerns.

Common Conditions Monitored

This test is often used in diabetes care to monitor proinsulin conversion, though it’s not a standard routine test. It may be part of specialized evaluations for insulin resistance, pancreatic disorders, or metabolic syndrome.

Reference range

INR: 0.8-1.2 (warfarin: 2.0-3.0)N/A

Specimen: serum

Inform your healthcare provider if you are taking blood thinners. No special preparation required.

Clinical interpretation

How abnormal results are interpreted and what conditions they suggest.

Clinical Significance: This test helps identify imbalances in insulin metabolism, which can affect blood sugar control. Elevated or altered peptide fragments may signal diabetes progression, insulin dysfunction, or other metabolic disorders that require medical attention.

Short name

Proinsulin/peptide C screening

Frequently asked questions

What does a high or low result mean?
High levels of certain peptide fragments may suggest inefficient insulin processing, which could relate to diabetes or other metabolic issues. Low or abnormal patterns may warrant further investigation by your healthcare provider.
Is fasting required for this test?
No fasting is usually required, but your doctor may provide specific instructions based on your medical history or the reason for the test.
How often should this test be done?
The frequency depends on your health needs. Your doctor will determine how often this test is necessary, often as part of diabetes management or if you have specific concerns about insulin function.
  1. 1
  2. 2
  3. 3

Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy